German-Korean Biotech Startup Koralo Announces Clinical Research Update and Expansion Strategy
German-Korean biotech startup Koralo has announced an update regarding its ongoing research and development activities, alongside its broader operational expansion plans. The company stated that it recently conducted a clinical study in the United States as part of its continued efforts to develop postbiotic-based ingredients using its proprietary co-fermentation technology. The research forms part of Koralo’s wider initiative to explore applications of fermentation-derived compounds across multiple sectors. Koralo is currently operating a manufacturing base in Jeonju, South Korea, where it is leveraging local fermentation infrastructure to support its production and…
Read More